[
  {
    "objectID": "initial_pres.html",
    "href": "initial_pres.html",
    "title": "Initial Analysis",
    "section": "",
    "text": "Initial Data Summary\n\nGender\n\n\n\n\n\n\n\n\nGender\nCount\n\n\n\n\nFemale\n105\n\n\nMale\n174\n\n\n\n\n\n\n\n\n\nDiagnosis Age\n\n\n\n\n\n\n\n\nStatistic\nValue\n\n\n\n\nMin.\n31.00000\n\n\n1st Qu.\n59.00000\n\n\nMedian\n66.00000\n\n\nMean\n65.45878\n\n\n3rd Qu.\n74.00000\n\n\nMax.\n91.00000\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nRace\n\n\n\n\n\n\n\n\n\n\n\nVital Status\n\n\n\n\n\n\n\n\nStatus\nCount\n\n\n\n\nalive\n43\n\n\ndead\n204\n\n\nlost to follow up\n32\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nTreatment Summary\n\nRadiation Treatment\n\n\n\n\n\n\n\n\nCycles\nCount\nPercentage\n\n\n\n\n0\n68\n25.47\n\n\n&lt;1\n18\n6.74\n\n\n1\n168\n62.92\n\n\n&lt;2\n6\n2.25\n\n\n2\n6\n2.25\n\n\n≥3\n1\n0.37\n\n\n\n\n\n\n\n\n\nChemotherapy Treatment\n\n\n\n\n\n\n\n\nCycles\nCount\nPercentage\n\n\n\n\n0\n86\n32.33\n\n\n&lt;1\n19\n7.14\n\n\n1\n57\n21.43\n\n\n&lt;2\n3\n1.13\n\n\n2\n16\n6.02\n\n\n≥3\n85\n31.95\n\n\n\n\n\n\n\n\n\nStupp Protocol\n\n\n\n\n\n\n\n\nCycles\nCount\n\n\n\n\nno\n93\n\n\nyes\n162\n\n\n\n\n\n\n\n\n\n\nTime from Surgery to Start of Radiation\n\n\n\n\n\n\n\n\nStatistics\nValue\n\n\n\n\nMin.\n1.000000\n\n\n1st Qu.\n4.000000\n\n\nMedian\n6.000000\n\n\nMean\n7.997297\n\n\n3rd Qu.\n8.000000\n\n\nMax.\n267.000000\n\n\n\n\n\n\n\n\n\nNumber of Lobes Involved\n\n\n\n\n\n\n\n\nLobes\nCount\n\n\n\n\n0\n18\n\n\n1\n166\n\n\n2\n81\n\n\n3\n12\n\n\n4\n2\n\n\n\n\n\n\n\n\n\n\nPath Data\n\nMicrovascular Proliferation\n\n\n\n\n\n\n\n\nmicrovascular_proliferation\nCount\n\n\n\n\nno\n82\n\n\nunknown\n1\n\n\nyes\n193\n\n\n\n\n\n\n\n\n\nNecrosis\n\n\n\n\n\n\n\n\nnecrosis\nCount\n\n\n\n\nno\n46\n\n\nyes\n232\n\n\n\n\n\n\n\n\n\nCaris?\n\n\n\n\n\n\n\n\ncaris\nCount\n\n\n\n\nno\n202\n\n\nyes\n74\n\n\n\n\n\n\n\n\n\nEGFR Amplification\n\n\n\n\n\n\n\n\nEGFR_amplification\nCount\n\n\n\n\nno\n54\n\n\nunknown\n1\n\n\nyes\n24\n\n\n\n\n\n\n\n\n\n+7/-10 Chromosomal Alterations\n\n\n\n\n\n\n\n\nchromosomal710\nCount\n\n\n\n\nno\n50\n\n\nyes\n21\n\n\n\n\n\n\n\n\n\nTERT Promotor\n\n\n\n\n\n\n\n\nTERT_promoter\nCount\n\n\n\n\nno\n13\n\n\nyes\n67\n\n\n\n\n\n\n\n\n\nTERT Promotor\n\n\n\n\n\n\n\n\npTERT_variant\nCount\n\n\n\n\nC124T\n38\n\n\nC146T\n12\n\n\ng.1295220T?\n1\n\n\ninconclusive\n1\n\n\nunknown\n1\n\n\n\n\n\n\n\n\n\nMGMT Methylation\n\n\n\n\n\n\n\n\nMGMT_methylation\nCount\n\n\n\n\nM\n86\n\n\nUM\n178\n\n\nUM pre RT/TMZ, M post\n1\n\n\n\n\n\n\n\n\n\nKi67\n\n\n\n\n\n\n\n\nKi67_LI\nCount\n\n\n\n\n15%\n20\n\n\n&lt;15%\n44\n\n\n&gt;15%\n175\n\n\n\n\n\n\n\n\n\nATRX\n\n\n\n\n\n\n\n\nATRX\nCount\n\n\n\n\ninconclusive\n3\n\n\nloss\n5\n\n\nretained\n224\n\n\nunknown\n8\n\n\n\n\n\n\n\n\n\nMitotic Activity\n\n\n\n\n\n\n\n\nmitotic_activity_increase\nCount\n\n\n\n\n0\n4\n\n\n1to5\n51\n\n\n6to10\n39\n\n\n&gt;10\n30\n\n\natypical\n1\n\n\nbrisk\n5\n\n\ndifficult to find\n2\n\n\ndifficult to identify\n1\n\n\neasily identified\n9\n\n\nfew\n2\n\n\nfrequent\n4\n\n\nidentified\n2\n\n\ninconspicuous\n1\n\n\nincreased\n17\n\n\ninfrequent\n3\n\n\nmany\n5\n\n\nmany occasional\n4\n\n\nmany rare\n1\n\n\nnumerous\n1\n\n\noccasional\n30\n\n\npresent\n5\n\n\nrare\n6\n\n\nscattered\n29\n\n\nseveral\n1\n\n\nsome\n3\n\n\n\n\n\n\n\n\n\n\nInitial Analysis\n\nOverall Survival\nThis is a general picture of the overall survival of everyone in the data set. The red line represents the median value.\n\n\n\n\n\n\n\n\n\n\n\n\nSignificant Variables\nBelow are all of the individually significant variables I found in the dataset.\n\n\n\n\n\n\n\n\nvariable\np_value\n\n\n\n\nnum_radiations\n0.000000e+00\n\n\nnum_chemo\n0.000000e+00\n\n\nreceived_stupp\n1.063594e-13\n\n\ndiscontinued_stupps\n1.701831e-08\n\n\nnum_surgeries\n2.573419e-08\n\n\nresection_extent\n7.610069e-08\n\n\ndiscontinued_treatment\n7.401595e-07\n\n\ncaris\n8.531733e-03\n\n\nMGMT_methylation\n2.720695e-02\n\n\ntemporal\n2.982019e-02\n\n\n\n\n\n\n\n\n\nK-M Curves for Sig Variables\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nNext Steps\nThe next steps for the analysis will be:\n- Work on cleaning, categorising, and analysing the other mutations, increased mitotic activity values, and lobes involved.\n- Looking at how these variables may interact and influence each other and the corresponding survival time.\n- Meeting with my professor next week to discuss any avenues of analysis I may be missing to ensure that all of the data work is strong."
  }
]